E. Jimenez-Aguilar

Harmonization of Tumor Mutational Burden Quantification and Association With Response to Immune Checkpoint Blockade in Non–Small-Cell Lung Cancer

Natalie I. Vokes, David Liu, Biagio Ricciuti et al. · JCO Precision Oncology · 2019 · 119 citations · Full text

Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non–small cell lung cancer and a poor performance status

Joao V. Alessi, Biagio Ricciuti, E. Jimenez-Aguilar et al. · Journal for ImmunoTherapy of Cancer · 2020 · 57 citations · Full text

Lurbinectedin in the Treatment of Relapsed Small Cell Lung Cancer

Javier Baena, Andrea Modrego, Ali Zeaiter et al. · Future Oncology · 2021 · 26 citations

Tumor Biology, Medicine, Pharmacology +12

OA11.04 Lurbinectedin With Irinotecan in Relapsed Small Cell Lung Cancer. Results From the Expansion Stage of a Phase I-II Trial

Santiago Ponce-Aix, Gregory M. Coté, Alejandro Falcón et al. · Journal of Thoracic Oncology · 2021 · 13 citations · Full text

Phase I-ii Trial, Oa11.04 Lurbinectedin, Medicine +9